Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, with a corresponding US DMF Number 33282.
Remarkably, this DMF maintains an Active status since its submission on November 14, 2018, highlighting commitment to regulatory compliance.